Insider · CIK 0001202286
HOWSON TAMAR D
Reports to the SEC for 12 companies · NEW YORK, NY
Transactions
50
Companies
12
Filings
15
CIK
0001202286
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-29 | IMUXIMMUNIC, INC. · Stock OptionA Award | — |
| 2025-06-05 | IMUXIMMUNIC, INC. · Stock OptionA Award | — |
| 2024-06-11 | IMUXIMMUNIC, INC. · Stock OptionA Award | — |
| 2024-03-04 | IMUXIMMUNIC, INC. · Stock OptionD Disposition to Issuer | — |
| 2024-03-04 | IMUXIMMUNIC, INC. · Stock OptionD Disposition to Issuer | — |
| 2024-03-04 | IMUXIMMUNIC, INC. · Stock OptionD Disposition to Issuer | — |
| 2024-03-04 | IMUXIMMUNIC, INC. · Stock OptionD Disposition to Issuer | — |
| 2024-03-04 | IMUXIMMUNIC, INC. · Stock OptionA Award | — |
| 2024-03-04 | IMUXIMMUNIC, INC. · Stock OptionD Disposition to Issuer | — |
| 2023-09-29 | LITSLite Strategy, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-06-28 | IMUXIMMUNIC, INC. · Stock OptionA Award | — |
| 2023-01-03 | CUECue Biopharma, Inc. · Stock Option (right to buy)A Award | — |
| 2022-07-05 | LITSLite Strategy, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-06-15 | IMUXIMMUNIC, INC. · Stock OptionA Award | — |
| 2022-01-03 | CUECue Biopharma, Inc. · Stock Option (right to buy)A Award | — |
| 2021-07-01 | LITSLite Strategy, Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-06-10 | IMUXIMMUNIC, INC. · Stock OptionA Award | — |
| 2021-01-04 | CUECue Biopharma, Inc. · Stock Option (right to buy)A Award | — |
| 2020-09-17 | CUECue Biopharma, Inc. · Stock Option (right to buy)A Award | — |
| 2020-07-02 | IMUXIMMUNIC, INC. · Stock OptionA Award | — |
| 2020-07-02 | LITSLite Strategy, Inc. · Stock Option (Right to Buy)A Award | — |
| 2019-10-11 | IMUXIMMUNIC, INC. · Stock OptionA Award | — |
| 2019-07-01 | LITSLite Strategy, Inc. · Stock Option (Right to Buy)A Award | — |
| 2018-07-26 | VIVSVivoSim Labs, INC. · Stock Option (Right to Buy)A Award | — |
| 2017-08-24 | VIVSVivoSim Labs, INC. · Stock Option (Right to Buy)A Award | — |
| 2017-04-10 | HEPAHepion Pharmaceuticals, Inc. · Stock OptionsA Award | — |
| 2016-08-17 | VIVSVivoSim Labs, INC. · Stock Option (Right to Buy)A Award | — |
| 2016-08-17 | VIVSVivoSim Labs, INC.A Award | — |
| 2015-08-20 | VIVSVivoSim Labs, INC. · Stock Option (Right to Buy)A Award | — |
| 2015-05-28 | OTLCOncotelic Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2015-03-17 | Allergan plcF Tax Payment | −$169K |
| 2014-08-20 | VIVSVivoSim Labs, INC. · Stock Option (Right to Buy)A Award | — |
| 2014-08-05 | IDENIX PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer | — |
| 2014-08-05 | IDENIX PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer | — |
| 2014-08-05 | IDENIX PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer | — |
| 2014-08-05 | IDENIX PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer | — |
| 2014-08-05 | IDENIX PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer | — |
| 2014-08-05 | IDENIX PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer | — |
| 2014-08-05 | IDENIX PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer | — |
| 2014-07-02 | OTLCOncotelic Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2014-01-02 | OTLCOncotelic Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2013-11-06 | Allergan plcS Sale | +$47.2K |
| 2013-10-01 | Allergan plcA Award | — |
| 2013-09-30 | Warner Chilcott plcD Disposition to Issuer | — |
| 2013-09-30 | Warner Chilcott plcOption to purchase ordinary shares par value $0.01 per shareD Disposition to Issuer | — |
| 2013-08-21 | VIVSVivoSim Labs, INC. · Stock Option (Right to Buy)A Award | — |
| 2013-07-01 | OTLCOncotelic Therapeutics, Inc.A Award | — |
| 2013-07-01 | OTLCOncotelic Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2013-06-06 | IDENIX PHARMACEUTICALS INCStock Option (Right to Buy)A Award | — |
| 2013-06-05 | VIVSVivoSim Labs, INC. · Stock Option (Right to Buy)A Award | — |
Recent filings
- 4HOWSON TAMAR D0001193805-26-000889SEC(opens sec.gov)
- 4HOWSON TAMAR D0001193805-25-000843SEC(opens sec.gov)
- 4HOWSON TAMAR D0001193805-24-000784SEC(opens sec.gov)
- 4HOWSON TAMAR D0001193805-24-000325SEC(opens sec.gov)
- 4HOWSON TAMAR D0000929638-23-002770SEC(opens sec.gov)
- 4HOWSON TAMAR D0001193805-23-000923SEC(opens sec.gov)
- 4HOWSON TAMAR D0001209191-23-001785SEC(opens sec.gov)
- 4HOWSON TAMAR D0000899243-22-025710SEC(opens sec.gov)
- 4HOWSON TAMAR D0001193805-22-000967SEC(opens sec.gov)
- 4HOWSON TAMAR D0000899243-22-001050SEC(opens sec.gov)
- 4HOWSON TAMAR D0001209191-21-045660SEC(opens sec.gov)
- 4HOWSON TAMAR D0001193805-21-000867SEC(opens sec.gov)
- 4HOWSON TAMAR D0000899243-21-000700SEC(opens sec.gov)
- 4HOWSON TAMAR D0001209191-20-051145SEC(opens sec.gov)
- 4HOWSON TAMAR D0000899243-20-018612SEC(opens sec.gov)
Companies
- Allergan plcDirector
- ARADIGM CORPDirector
- BRISTOL MYERS SQUIBB COSVP, Corp & Bus DevelopmentBMY
- Cue Biopharma, Inc.DirectorCUE
- Hepion Pharmaceuticals, Inc.DirectorHEPA
- IDENIX PHARMACEUTICALS INCDirector
- IMMUNIC, INC.DirectorIMUX
- Lite Strategy, Inc.DirectorLITS
- Oncotelic Therapeutics, Inc.DirectorOTLC
- SOLIGENIX, INC.DirectorSNGX
- VivoSim Labs, INC.DirectorVIVS
- Warner Chilcott plcDirector
Address
1200 AVENUE OF THE AMERICAS, SUITE 200
NEW YORK, NY, 10036